257 related articles for article (PubMed ID: 19706688)
1. A novel mechanism of sodium iodide symporter repression in differentiated thyroid cancer.
Smith VE; Read ML; Turnell AS; Watkins RJ; Watkinson JC; Lewy GD; Fong JC; James SR; Eggo MC; Boelaert K; Franklyn JA; McCabe CJ
J Cell Sci; 2009 Sep; 122(Pt 18):3393-402. PubMed ID: 19706688
[TBL] [Abstract][Full Text] [Related]
2. PTTG and PBF repress the human sodium iodide symporter.
Boelaert K; Smith VE; Stratford AL; Kogai T; Tannahill LA; Watkinson JC; Eggo MC; Franklyn JA; McCabe CJ
Oncogene; 2007 Jun; 26(30):4344-56. PubMed ID: 17297475
[TBL] [Abstract][Full Text] [Related]
3. Manipulation of PBF/PTTG1IP phosphorylation status; a potential new therapeutic strategy for improving radioiodine uptake in thyroid and other tumors.
Smith VE; Sharma N; Watkins RJ; Read ML; Ryan GA; Kwan PP; Martin A; Watkinson JC; Boelaert K; Franklyn JA; McCabe CJ
J Clin Endocrinol Metab; 2013 Jul; 98(7):2876-86. PubMed ID: 23678037
[TBL] [Abstract][Full Text] [Related]
4. PTTG-binding factor (PBF) is a novel regulator of the thyroid hormone transporter MCT8.
Smith VE; Read ML; Turnell AS; Sharma N; Lewy GD; Fong JC; Seed RI; Kwan P; Ryan G; Mehanna H; Chan SY; Darras VM; Boelaert K; Franklyn JA; McCabe CJ
Endocrinology; 2012 Jul; 153(7):3526-36. PubMed ID: 22535767
[TBL] [Abstract][Full Text] [Related]
5. Expression and function of the novel proto-oncogene PBF in thyroid cancer: a new target for augmenting radioiodine uptake.
Smith VE; Franklyn JA; McCabe CJ
J Endocrinol; 2011 Aug; 210(2):157-63. PubMed ID: 21450804
[TBL] [Abstract][Full Text] [Related]
6. Phosphoinositide-3-kinase inhibition induces sodium/iodide symporter expression in rat thyroid cells and human papillary thyroid cancer cells.
Kogai T; Sajid-Crockett S; Newmarch LS; Liu YY; Brent GA
J Endocrinol; 2008 Nov; 199(2):243-52. PubMed ID: 18762555
[TBL] [Abstract][Full Text] [Related]
7. Proto-oncogene PBF/PTTG1IP regulates thyroid cell growth and represses radioiodide treatment.
Read ML; Lewy GD; Fong JC; Sharma N; Seed RI; Smith VE; Gentilin E; Warfield A; Eggo MC; Knauf JA; Leadbeater WE; Watkinson JC; Franklyn JA; Boelaert K; McCabe CJ
Cancer Res; 2011 Oct; 71(19):6153-64. PubMed ID: 21844185
[TBL] [Abstract][Full Text] [Related]
8. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.
Filetti S; Bidart JM; Arturi F; Caillou B; Russo D; Schlumberger M
Eur J Endocrinol; 1999 Nov; 141(5):443-57. PubMed ID: 10576759
[TBL] [Abstract][Full Text] [Related]
9. Alpha-lipoic acid induces sodium iodide symporter expression in TPC-1 thyroid cancer cell line.
Choi HJ; Kim TY; Ruiz-Llorente S; Jeon MJ; Han JM; Kim WG; Shong YK; Kim WB
Nucl Med Biol; 2012 Nov; 39(8):1275-80. PubMed ID: 22995901
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of the human sodium/iodide symporter gene promoter in papillary thyroid carcinoma cell lines and normal thyroid cells.
Kogai T; Hershman JM; Motomura K; Endo T; Onaya T; Brent GA
Endocrinology; 2001 Aug; 142(8):3369-79. PubMed ID: 11459780
[TBL] [Abstract][Full Text] [Related]
11. Targeting Novel Sodium Iodide Symporter Interactors ADP-Ribosylation Factor 4 and Valosin-Containing Protein Enhances Radioiodine Uptake.
Fletcher A; Read ML; Thornton CEM; Larner DP; Poole VL; Brookes K; Nieto HR; Alshahrani M; Thompson RJ; Lavery GG; Landa I; Fagin JA; Campbell MJ; Boelaert K; Turnell AS; Smith VE; McCabe CJ
Cancer Res; 2020 Jan; 80(1):102-115. PubMed ID: 31672844
[TBL] [Abstract][Full Text] [Related]
12. Regulation of sodium iodide symporter gene expression in FRTL-5 rat thyroid cells.
Spitzweg C; Joba W; Morris JC; Heufelder AE
Thyroid; 1999 Aug; 9(8):821-30. PubMed ID: 10482376
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells.
Schmutzler C; Winzer R; Meissner-Weigl J; Köhrle J
Biochem Biophys Res Commun; 1997 Nov; 240(3):832-8. PubMed ID: 9398654
[TBL] [Abstract][Full Text] [Related]
14. Immunoanalysis indicates that the sodium iodide symporter is not overexpressed in intracellular compartments in thyroid and breast cancers.
Peyrottes I; Navarro V; Ondo-Mendez A; Marcellin D; Bellanger L; Marsault R; Lindenthal S; Ettore F; Darcourt J; Pourcher T
Eur J Endocrinol; 2009 Feb; 160(2):215-25. PubMed ID: 19029227
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of potential sodium-iodide symporter (NIS) inhibitors using a secondary Fischer rat thyroid follicular cell (FRTL-5) radioactive iodide uptake (RAIU) assay.
Buckalew AR; Wang J; Murr AS; Deisenroth C; Stewart WM; Stoker TE; Laws SC
Arch Toxicol; 2020 Mar; 94(3):873-885. PubMed ID: 32065294
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.
Kogai T; Taki K; Brent GA
Endocr Relat Cancer; 2006 Sep; 13(3):797-826. PubMed ID: 16954431
[TBL] [Abstract][Full Text] [Related]
17. Reintroducing the Sodium-Iodide Symporter to Anaplastic Thyroid Carcinoma.
Schmohl KA; Dolp P; Schug C; Knoop K; Klutz K; Schwenk N; Bartenstein P; Nelson PJ; Ogris M; Wagner E; Spitzweg C
Thyroid; 2017 Dec; 27(12):1534-1543. PubMed ID: 29032724
[TBL] [Abstract][Full Text] [Related]
18. The importance of sodium/iodide symporter (NIS) for thyroid cancer management.
Carvalho DP; Ferreira AC
Arq Bras Endocrinol Metabol; 2007 Jul; 51(5):672-82. PubMed ID: 17891230
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of microRNA-875-5p promotes radioiodine uptake in poorly differentiated thyroid carcinoma cells by upregulating sodium-iodide symporter.
Tang Y; Meng X; Yu X; Shang H; Chen S; Liao L; Dong J
J Endocrinol Invest; 2020 Apr; 43(4):439-450. PubMed ID: 31612419
[TBL] [Abstract][Full Text] [Related]
20. A Novel Tyrosine Kinase Inhibitor Can Augment Radioactive Iodine Uptake Through Endogenous Sodium/Iodide Symporter Expression in Anaplastic Thyroid Cancer.
Oh JM; Baek SH; Gangadaran P; Hong CM; Rajendran RL; Lee HW; Zhu L; Gopal A; Kalimuthu S; Jeong SY; Lee SW; Lee J; Ahn BC
Thyroid; 2020 Apr; 30(4):501-518. PubMed ID: 31928162
[No Abstract] [Full Text] [Related]
[Next] [New Search]
